References

1. Scottish Government (2024). Ending HIV Transmission Elimination in Scotland by 2030. HIV Transmission Elimination Delivery Plan (2023-26). Available from: https://www.gov.scot/publications/ending-hiv-transmission-scotland-2030-hiv-transmission-elimination-delivery-plan-2023-26/​
2. Public Health Scotland (2024). HIV in Scotland: HIV in Scotland: update to 31 December 2024. Available from: https://publichealthscotland.scot/media/35162/final-hiv-in-scotland-update-to-31-december-2024_checked.pdf
3. Scottish Medicines Consortium (SMC) (2017). Providing advice about status of all newly licenced medicine. emtricitabine/tenofovir disoproxil 200mg/245mg film-coated tablets (Truvada® ). Available from: https://scottishmedicines.org.uk/media/1620/emtricitabine_tenofovir_disoproxil_truvada_final_march_2017_for_website.pdf ​
4. Centre of Disease Control: https://www.cdc.gov/stophivtogether/hiv-prevention/prep.html​
5. McCormack et al (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, The Lancet, 387(10013): 53-60. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00056-2/fulltext. ​
6. Molina et al (2015). IPERGAY Study - On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 373(23):2237-46. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1506273 ​
7. Thingpen et al (2012). TDF2 study - Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. N Engl J Med. 2;367(5):423-34. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1110711 ​
8. Murnane et al (2013). Partners in PrEP Study - Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from the Partners PrEP Study. AIDS. 27(13): 2155-60. Available from: https://pubmed.ncbi.nlm.nih.gov/24384592/9​
9. Scottish Medicines Consortium.(2025). Advice on new medicines: cabotegravir prolonged-release suspension for injection and film- coated tablets (Apretude®) Available from: https://scottishmedicines.org.uk/media/8943/cabotegravir-apretude-final-jan-2025-for-website.pdf​
10. Estcourt et al (2021). Population level effectiveness of a national HIV pre-exposure prophylaxis programme in MSM. AIDS. 35(4); 665-673. Available from: https://pubmed.ncbi.nlm.nih.gov/33290298/ ​
11. BASHH/BHIVA (2025). Guidelines on the use of HIV pre-exposure prophylaxis (PrEP). Available from: https://bhiva.org/clinical-guideline/prep-guidelines/ ​
12. Medland et al. PrEP Suitability Guidance Scotland. ​
13. i-base (2025). UK guide to PrEP (July 2025). Available from: https://i-base.info/guides/prep